Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultrasound Obstet Gynecol ; 55(2): 226-232, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31008542

RESUMO

OBJECTIVES: Tricuspid valve dysplasia (TVD) and Ebstein's anomaly (EA) diagnosed by fetal echocardiography vary greatly in terms of clinical severity and prognosis. The Celermajer index and Simpson-Andrews-Sharland (SAS) score have been reported previously for the prediction of prognosis in cases of TVD/EA; however, they do not take into account the hemodynamic impact of left ventricular (LV) function, which has recently been implicated as being important in the pathophysiology of TVD/EA. The aim of this study was to develop a novel scoring system that includes LV function for the prediction of perinatal death in fetuses diagnosed with TVD/EA. METHODS: The clinical records of 36 fetuses diagnosed prenatally with TVD/EA between 2000 and 2015 in our hospital were reviewed. Univariate analysis was used to assess the association between perinatal death (defined as death between 22 weeks' gestation and 4 weeks after delivery) and gestational age at diagnosis, cardiothoracic area ratio (CTAR), degree of pulmonary artery flow, direction of ductal flow, right-to-left ventricular diameter ratio, tricuspid regurgitation (TR) maximum velocity, Celermajer index, SAS score and LV-Tei index. A new prognostic score, the TRIPP score (TRIcuspid malformation Prognosis Prediction score), was developed using the parameters found to be associated significantly with perinatal death. The predictive value of this score was assessed in an additional nine fetuses diagnosed with TVD/EA. RESULTS: Thirty-six fetuses were diagnosed prenatally with TVD/EA, two of which were terminated, one was lost to follow-up and two died before 22 weeks' gestation. Of the 31 included fetuses, 10 (32%) died in the perinatal period. Univariate analysis demonstrated that TR maximum velocity was significantly lower (2.22 ± 0.17 m/s vs 3.26 ± 0.12 m/s; P < 0.001) and SAS score was significantly higher (5.7 ± 0.6 points vs 2.8 ± 0.4 points; P = 0.0014) in cases of perinatal death than in surviving fetuses. The degree of pulmonary artery flow and the direction of ductal flow were also associated significantly with perinatal death (P < 0.01 for both). Notably, LV-Tei index was significantly higher in cases of perinatal death than in surviving fetuses (0.81 ± 0.08 vs 0.50 ± 0.05; P < 0.001). In contrast, there was no significant difference in Celermajer index, CTAR or right-to-left ventricular diameter ratio. Finally, we established a novel combinatorial scoring system, the TRIPP score, including the four significant factors: TR maximum velocity, pulmonary artery flow, direction of ductal flow and LV-Tei index. The TRIPP score was found to predict efficiently perinatal mortality in fetuses with TVD/EA. CONCLUSIONS: Our novel combinatorial score of echocardiographic parameters, the TRIPP score, including LV-Tei index, is easy to measure and provides a good tool for the prediction of perinatal mortality in fetuses diagnosed prenatally with TVD/EA. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.


Assuntos
Regras de Decisão Clínica , Anomalia de Ebstein/diagnóstico , Ecocardiografia/métodos , Cardiopatias Congênitas/diagnóstico , Diagnóstico Pré-Natal/métodos , Insuficiência da Valva Tricúspide/diagnóstico , Anomalia de Ebstein/embriologia , Anomalia de Ebstein/mortalidade , Feminino , Idade Gestacional , Cardiopatias Congênitas/embriologia , Cardiopatias Congênitas/mortalidade , Humanos , Recém-Nascido , Morte Perinatal/etiologia , Mortalidade Perinatal , Valor Preditivo dos Testes , Gravidez , Prognóstico , Estudos Retrospectivos , Valva Tricúspide/embriologia , Insuficiência da Valva Tricúspide/embriologia , Insuficiência da Valva Tricúspide/mortalidade , Função Ventricular Esquerda
3.
Bull Am Acad Psychiatry Law ; 23(4): 607-11, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8639988

RESUMO

Pharmacological management of persistent aggression in patients with schizophrenia is a difficult clinical dilemma. Clozapine has been shown to be an effective agent in this regard. This study sought to compare the symptomatic response on the Brief Psychiatric Rating Scale (BPRS) between hostile schizophrenic patients and patients without aggression. While dramatic improvements were evident in aggression, both groups were indistinguishable with respect to BPRS response. These results suggest that clozapine may have a selective antiaggressive effect.


Assuntos
Agressão/efeitos dos fármacos , Antipsicóticos/uso terapêutico , Clozapina/uso terapêutico , Esquizofrenia/tratamento farmacológico , Psicologia do Esquizofrênico , Violência/prevenção & controle , Adulto , Antipsicóticos/efeitos adversos , Clozapina/efeitos adversos , Feminino , Hostilidade , Humanos , Masculino , Pessoa de Meia-Idade , Escalas de Graduação Psiquiátrica , Violência/psicologia
4.
J Virol Methods ; 45(2): 219-28, 1993 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-7509340

RESUMO

The appearance of cytomegalovirus (CMV) proteins in infected fibroblasts was determined by flow cytometry. The sequential production of immediate early (IE), early (E), and late (L) proteins reacting with respective monoclonal antibodies (mAbs) E13, 58/5, and 24/4 was determined in fibroblasts infected with the AD-169 strain of CMV. The percentage of cells expressing CMV proteins and the intensity of fluorescence within cells were determined from day 1 to day 7 post-infection. The effect of interferons (IFNs) alpha, beta, gamma on expression of CMV proteins was analyzed using flow cytometry. IFNs inhibited E and L protein production at days 3 and 6 post-infection in a dose-dependent manner. This inhibitory effect on protein expression was associated with a reduction in release of infectious CMV into culture media. The method described here for detection of CMV proteins using flow cytometry may be useful for basic studies of gene expression and for diagnostic purposes.


Assuntos
Citomegalovirus/efeitos dos fármacos , Citometria de Fluxo/métodos , Interferons/farmacologia , Proteínas Virais/biossíntese , Anticorpos Monoclonais , Linhagem Celular , Citomegalovirus/imunologia , Citomegalovirus/fisiologia , Estudos de Avaliação como Assunto , Humanos , Interferon Tipo I/farmacologia , Interferon beta/farmacologia , Interferon gama/farmacologia , Proteínas Recombinantes , Proteínas Virais/análise , Proteínas Virais/imunologia , Virologia/métodos , Replicação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...